Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2004 / Cilt: 50 - Sayı: 4

The effects of acute phase reactants and lesion size on functional outcome in stroke patients

Akut faz reaktanları ve lezyon büyüklüğünün inmeli hastalarda fonksiyonel prognoza etkileri

Pages
17–20
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was also a positive correlation between the C-reactive protein level and the lesion size (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lesion size and acute phase reactants have been claimed to predict the prognosis in stroke, recently.
📊
Key Findings & Data:The aim of this study was to evaluate the relationship between the lesion size, acute phase reactants, and early functional outcome after ischemic stroke.In 64 patients with acute ischemic stroke, serum C-reactive protein, fibrinogen and ceruloplasmin levels were studied in the first 24 hours of the event.
💡
Conclusion & Impact:There was also a positive correlation between the C-reactive protein level and the lesion size (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Lesion size and acute phase reactants have been claimed to predict the prognosis in stroke, recently. However, there are contradictory results in the literature. The aim of this study was to evaluate the relationship between the lesion size, acute phase reactants, and early functional outcome after ischemic stroke.In 64 patients with acute ischemic stroke, serum C-reactive protein, fibrinogen and ceruloplasmin levels were studied in the first 24 hours of the event. All patients underwent brain scanning with tomography. Functional status of the patients were evaluated with Barthel Index in the first 24 hours and after 3 months. There was a positive correlation between the 3rd month and 1st day Barthel Index, whereas there was a negative correlation between the 3rd month Barthel Index and C-reactive protein, ceruloplasmin, lesion size and age. There was also a positive correlation between the C-reactive protein level and the lesion size (p

Özet

Son yıllarda, inmeli hastalarda prognozun akut faz reaktanları ve lezyon büyüklüğü ile ilişkili olabileceği öne sürülmüştür, ancak literatürde bu konuda birbirinden farklı sonuçlar vardır. Bu çalışmanın amacı inmeli hastalarda, erken dönemdeki fonksiyonel prognozun lezyon büyüklüğü ve akut faz reaktanları ile ilişkisini araştırmaktır. Akut iskemik inme tanısı konmuş olan 64 hastada ilk 24 saat içinde serum C-reaktif protein, fibrinojen, ve serüloplazmin düzeyleri ölçüldü. Tüm hastalara beyin tomografisi çekildi. Hastaların fonksiyonel durumları yatışlarının ilk 24 saati içinde ve olaydan 3 ay sonra Barthel İndeksi ile değerlendirildi. Üçüncü ay Barthel indeksi ile birinci gün Barthel indeksi arasında pozitif, üçüncü ay Barthel indeksi ile C-reaktif protein, serüloplazmin, lezyon büyüklüğü ve yaş arasında ise negatif korelasyon bulundu. Lezyon büyüklüğü ile C-reaktif protein arasında da pozitif korelasyon saptandı (p

🔖

Cite This Article

BOLAYIR, E., AKYÜZ, A., TOPAKTAŞ, S., TAŞ, A., YILMAZ, K., KAPTANOĞLU, E. (2022). The effects of acute phase reactants and lesion size on functional outcome in stroke patients. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 50 - Sayı: 4, 17–20. https://ajindex.com/articles/629299

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Gussekloo J, Schaap MCL, Frolich M, et al. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol 2000; 20: 1047-51
  2. Anuk T, Assayag EB, Rotstein R, et al. Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand 2002; 106: 196-9
  3. Canova CR, Courtin C, Reinhart WH. C-reactive protein in cerebro-vascular events. Atherosclerosis 1999; 147: 49-53
  4. İyigün İ, Bakırcı Y. Plasma concentrations of C-reactive protein and fibrinogen in ischaemic stroke. J Int Med Res 2002; 30: 591-6
  5. Vila N, Filella X, Deulofeu R, et al. Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci 1999; 162: 185-8
  6. Collin C, Wade DT, Davies S, et al. The Barthel ADL index: a reliability study. Int Disabil Stud 1988; 10: 61-3
  7. Winbeck K, Poppert H, Etgen T, et al. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002; 33: 2459-64
  8. Napoli MD, Papa F, Bocola V. C-reactive protein in ischemic stroke. An independant prognostic factor. Stroke 2001; 32: 917-24
  9. Napoli MD, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001; 32: 133-8
  10. Armengou A, Davalos A, Fernandez-Real JM, et al. Serum ferritin concentrations are not modified in the acute phase of ischemic stroke. Stroke 1998; 29: 258-60
  11. Napoli MD, Papa F. C-Reactive protein in ischemic stroke. Stroke 2002; 33: 2146-7
  12. Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol 2002; 9: 425-32
  13. Marniemi J, Jarvisalo J, Toikka T, et al. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population. Int J Epidemiol 1998; 27: 799-807
  14. Engstrom G, Lind P, Hedblad B, et al. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 2002; 33: 2744-9
  15. Ionescu DA, Hategan D, Jipescu I, et al. Early prognosis of survival or death after a recent stroke by blood levels of acute-phase proteins. Rom J Neurol Psychiatry 1991; 29: 143-7
  16. Emsley HCA, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischemic stroke: relationships with infection and atherosc